Point-of-Care Molecular Diagnostics Market Size, Top Players, and Forecast by 2028
Point-of-Care Molecular Diagnostics Market: Size and Share
-
CAGR (2021 - 2028)13.4% -
Market Size 2021
US$ 2.23 Billion -
Market Size 2028
US$ 5.38 Billion
Market Dynamics
- Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
- Rising Incidences of Infectious Diseases
- Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits Across Residential Setting
- Rising R&D and Innovation in Point- of-Care Molecular Diagnostics
Market Segmentation
Product & Services - Assays and Kits
- Instruments
- Services and Software
Technology - PCR
- Isothermal Nucleic Acid Amplification Technology
Other Technologies)Application - Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Other Applications
Point-of-Care Molecular Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics
The Point-of-Care Molecular Diagnostics Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Point-of-Care Molecular Diagnostics Market are:
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Enzo Biochem, Inc.
- Abbott
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Point-of-Care Molecular Diagnostics Market top key players overview
Get Free Sample For